SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-21-003712
Filing Date
2021-01-07
Accepted
2021-01-07 07:29:59
Documents
8
Period of Report
2021-01-07

Document Format Files

Seq Description Document Type Size
1 6-K d67538d6k.htm 6-K 18467
2 EX-5.1 d67538dex51.htm EX-5.1 32538
3 EX-10.1 d67538dex101.htm EX-10.1 254088
4 EX-10.2 d67538dex102.htm EX-10.2 75806
5 EX-99.1 d67538dex991.htm EX-99.1 11964
6 GRAPHIC g67538dsp6.jpg GRAPHIC 6142
7 GRAPHIC g67538g0107015020947.jpg GRAPHIC 4975
8 GRAPHIC g67538g0107015021266.jpg GRAPHIC 2871
  Complete submission text file 0001193125-21-003712.txt   413770
Mailing Address RUE EDOUARD BELIN 12 MONT-SAINT-GUIBERT C9 1435
Business Address RUE EDOUARD BELIN 12 MONT-SAINT-GUIBERT C9 1435 32 10 394 100
Celyad Oncology SA (Filer) CIK: 0001637890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37452 | Film No.: 21512993
SIC: 2834 Pharmaceutical Preparations